Robot-Assisted Closed Reduction and Internal Fixation for Femoral Shaft Fractures
Robot-Assisted Versus Traditional Closed Reduction and Internal Fixation for Femoral Shaft Fractures: A Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the safety and efficacy of robot-assisted closed reduction for patients with femoral shaft fractures. The main questions it aims to answer are: Does robot-assisted closed reduction provide a statistically significant improvement in the excellent and good reduction rates compared to conventional surgeon-performed reduction? How do the two reduction methods compare in terms of surgical efficiency, fracture healing, and patient functional outcomes? Researchers will compare the robot-assisted closed reduction group to the conventional surgeon-performed reduction group to see if robot-assisted surgery improves the precision of fracture reduction, stability of alignment, and post-operative functional recovery while minimizing trauma. Participants will: Undergo standardized screening to ensure they meet the inclusion criteria for acute, unilateral, closed femoral shaft fractures (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association \[AO/OTA\] classification 32). Be randomized in a 1:1 ratio to receive either robot-assisted closed reduction or traditional surgeon-performed closed reduction, both followed by internal fixation. Complete standardized perioperative management and follow-up assessments at 1, 3, 6, and 12 months post-surgery, including functional scales such as the Lower Extremity Functional Scale (LEFS) and the EuroQol Five-Dimensional Five-Level questionnaire (EQ-5D-5L), as well as radiographic imaging to monitor bone healing and potential complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2026
CompletedFirst Submitted
Initial submission to the registry
July 8, 2026
CompletedFirst Posted
Study publicly available on registry
July 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 29, 2028
July 31, 2026
July 1, 2026
2.5 years
July 8, 2026
July 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of Excellent or Good Closed Fracture Reduction Assessed by Postoperative Low-Dose CT-Based 3D Quantitative Reduction Grading Criteria
Closed fracture reduction will be assessed on postoperative CT using a 3D quantitative grading system. Three dimensions will be graded as Excellent, Good, Fair, or Poor: displacement, angular deformity, and rotational deformity. The thresholds are \<=3 mm/degree for Excellent, \>3-5 mm/degree for Good, \>5-10 mm/degree for Fair, and \>10 mm/degree for Poor. The final grade will be the lowest grade across the three dimensions, and the excellent/good rate is the percentage of participants with a final grade of Excellent or Good.
From completion of surgery to postoperative low-dose CT assessment, assessed up to 2 weeks after surgery
Secondary Outcomes (12)
Total Operation Time Measured in Minutes
From initial skin incision to completion of skin closure, assessed up to 8 hours
Intraoperative Blood Loss Measured in Milliliters
From initial skin incision to completion of skin closure, assessed up to 8 hours
Change from Baseline in Lower Extremity Functional Scale Score (LEFS)
From baseline to 1 month, 3 months, 6 months, and 12 months after surgery
Change from Baseline in EuroQol 5-Dimension 5-Level Score( EQ-5D-5L)
From baseline to 1 month, 3 months, 6 months, and 12 months after surgery
Number of Intraoperative C-Arm Fluoroscopy Shots
From initial skin incision to completion of skin closure, assessed up to 8 hours
- +7 more secondary outcomes
Study Arms (2)
Robot-Assisted Close Reduction
EXPERIMENTALPatients in this arm will undergo autonomous closed reduction of the fracture assisted by a robotic system, followed by internal fixation performed by the surgeon.
Traditional Close Reduction
ACTIVE COMPARATORPatients in this arm will undergo traditional closed reduction (or open reduction if necessary) performed manually by the surgeon, followed by conventional internal fixation.
Interventions
Patients in this group will undergo robotic-assisted closed reduction of the femoral shaft fracture. The procedure utilizes a robotic system for intraoperative navigation and automated reduction planning based on preoperative computed tomography (CT) imaging. The robotic system assists the surgeon in achieving precise fracture alignment. Following successful reduction, routine internal fixation (intramedullary nailing) will be performed by the surgeon.
Patients in this group will undergo traditional manual closed reduction of the femoral shaft fracture. The reduction will be performed by the surgeon using standardized traction and manipulation techniques under real-time fluoroscopic guidance. Following manual reduction, routine internal fixation (intramedullary nailing) will be performed by the surgeon.
Eligibility Criteria
You may qualify if:
- Age 18 to 80 years, inclusive.
- Unilateral, acute, closed femoral shaft fracture.
- AO/OTA classification 32-A, 32-B, or 32-C femoral shaft fracture.
- Time from injury to surgery no more than 21 days.
- Ability to walk independently before injury, with or without assistive devices.
- Ability to provide written informed consent.
You may not qualify if:
- Open fracture.
- Multiple severe trauma requiring immediate priority management.
- Asymmetry of the lower limbs.
- History of ipsilateral femoral shaft malunion.
- History of ipsilateral femoral deformity that significantly affects assessment of - limb rotation or length.
- Ipsilateral fracture at another site.
- Pathological fracture caused by tumor, metabolic bone disease, or other underlying bone pathology.
- Complex hardware from previous ipsilateral surgery.
- History of ipsilateral surgery that significantly affects clinical or radiographic evaluation.
- Active infection.
- Severe underlying medical condition that makes the patient unable to tolerate surgery.
- Cognitive impairment that prevents study participation or follow-up.
- Poor compliance with study procedures or follow-up.
- Pregnancy or lactation.
- Judged by the investigators to be unsuitable for enrollment.
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Jishuitan Hospitallead
- Beihang Universitycollaborator
- Aerospace Center Hospitalcollaborator
Study Sites (1)
Beijing Jishuitan Hospital
Beijing, Beijing Municipality, 100035, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2026
First Posted
July 31, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
December 29, 2028
Study Completion (Estimated)
December 29, 2028
Last Updated
July 31, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share